Effet protecteur des alpha-bloquants dans la Covid-19

INTRODUCTION: Research data suggests that alpha-1 adrenergic receptor antagonists may be effective in reducing mortality from hyper-inflammation. We set out to verify this hypothesis. Our study aimed to examine the link between the use of alpha blockers and reduction in the mortality linked to COVID...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouchareb, S., Bouyahia, C., Baudouin, E., Neiss, M., Duron, E., Brunetti, N., Guichardon, M., Trivalle, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2022
Materias:
Données Fondamentales
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035364/
http://dx.doi.org/10.1016/j.npg.2022.03.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035364/
http://dx.doi.org/10.1016/j.npg.2022.03.002

Ejemplares similares